+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 65Years
All Genders
ID07667569

Evaluation of ACT-777991 Safety and Efficacy in Adults With Non-Segmental Vitiligo Using Daily Oral Tablets Compared to Placebo

Led by Idorsia Pharmaceuticals Ltd. · Updated on 2026-11-02

30

Participants Needed

5

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating how well ACT-777991 works, its safety, and how well it is tolerated by adults with non-segmental vitiligo. The main goal is to find out if ACT-777991 can help restore skin color on the face compared to a placebo, which is an inactive treatment. This phase 2a clinical trial is randomized, double-blind, and placebo-controlled, aiming to assess the treatments effects in adults aged 18 to 65 with this condition. Participants will be randomly assigned in a 21 ratio to receive either ACT-777991 tablets or placebo tablets taken orally every day for 24 weeks. The trial includes three periods screening to confirm eligibility, a 24-week treatment period, and a follow-up period lasting up to 37 days after treatment ends. During treatment, participants will take the assigned tablets daily and attend scheduled clinic visits. Throughout the study, participants will visit the clinic seven times for check-ups and tests. Researchers will monitor changes in the facial Vitiligo Area Scoring Index F-VASI at multiple points, including weeks 4, 8, 16, and 24, using both independent blinded readings and investigator assessments. Other assessments include total body vitiligo area, safety labs, vital signs, and heart monitoring. After treatment, participants will have a follow-up visit to assess any ongoing effects, with the entire trial lasting about 33 weeks per participant.

CONDITIONS

Brief Title

A Study to Learn How Safe ACT-777991 is and How Well it Works in Adults With Non-segmental Vitiligo

Research Team

C

Clinical Trial Information USA

C

Clinical Trial Information Europe

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here